{"id": "article-24241_0", "title": "Lhermitte Sign -- Continuing Education Activity", "content": "This article reviews one of the paroxysmal symptom/pain syndromes, Lhermitte's sign, a transient electric shock sensation down the spine and extremities caused by neck flexion. It is most notably caused by multiple sclerosis (MS) but is caused by numerous other lesions of the posterior columns of the cervical spinal cord. Lhermitte's sign is also classified as one of the paroxysmal pain syndromes of multiple sclerosis, a chronic, predominantly immune-mediated disease of the central nervous system. It is one of the most common causes of neurological disability in young adults globally and can cause many other neurological clinical symptoms, including mononuclear painful visual loss, spinal cord hemiparesis, mono/paraparesis, hypoesthesia, dysesthesia, paraesthesia, urinary and/or sphincter dysfunction, diplopia, oscillopsia, vertigo, gait ataxia, dysmetria, intentional/postural tremor, facial paresis, faciobrachial\u2013crural hemiparesis, and faciobrachial\u2013crural hemihypesthesia. This activity reviews the definition, etiology, pathophysiology, clinical and physical exam, considerations, and treatments of Lhermitte's sign.", "contents": "Lhermitte Sign -- Continuing Education Activity. This article reviews one of the paroxysmal symptom/pain syndromes, Lhermitte's sign, a transient electric shock sensation down the spine and extremities caused by neck flexion. It is most notably caused by multiple sclerosis (MS) but is caused by numerous other lesions of the posterior columns of the cervical spinal cord. Lhermitte's sign is also classified as one of the paroxysmal pain syndromes of multiple sclerosis, a chronic, predominantly immune-mediated disease of the central nervous system. It is one of the most common causes of neurological disability in young adults globally and can cause many other neurological clinical symptoms, including mononuclear painful visual loss, spinal cord hemiparesis, mono/paraparesis, hypoesthesia, dysesthesia, paraesthesia, urinary and/or sphincter dysfunction, diplopia, oscillopsia, vertigo, gait ataxia, dysmetria, intentional/postural tremor, facial paresis, faciobrachial\u2013crural hemiparesis, and faciobrachial\u2013crural hemihypesthesia. This activity reviews the definition, etiology, pathophysiology, clinical and physical exam, considerations, and treatments of Lhermitte's sign."}
{"id": "article-24241_1", "title": "Lhermitte Sign -- Continuing Education Activity", "content": "Objectives: Describe the various reported causes of Lhermitte's sign. Identify key clinical and physical exam findings of Lhermitte's sign and how to elicit it at the bedside. Summarize the experimental treatment modalities for patients with Lhermitte's sign. Explain strategies to improve care coordination among interprofessional team members to improve outcomes for patients affected by Lhermitte's sign. Access free multiple choice questions on this topic.", "contents": "Lhermitte Sign -- Continuing Education Activity. Objectives: Describe the various reported causes of Lhermitte's sign. Identify key clinical and physical exam findings of Lhermitte's sign and how to elicit it at the bedside. Summarize the experimental treatment modalities for patients with Lhermitte's sign. Explain strategies to improve care coordination among interprofessional team members to improve outcomes for patients affected by Lhermitte's sign. Access free multiple choice questions on this topic."}
{"id": "article-24241_2", "title": "Lhermitte Sign -- Introduction", "content": "Lhermitte's sign (also known as Lhermitte's phenomenon\u00a0or the barber chair phenomenon) is the term used that describes a transient sensation of an electric shock that extends down the spine and extremities upon flexion and/or movement of the neck. It was first described by Marie and Chatelin in 1917, but was\u00a0erroneously first credited to Babinski and Dubois,\u00a0and thenafter credited to Jean Jaque Lhermitte through the seminal paper Les douleurs \u00e0 type de d\u00e9charge \u00e9lectrique cons\u00e9cutives \u00e0 la flexion c\u00e9phalique dans la scl\u00e9rose en plaques: Un cas de forme sensitive de la scl\u00e9rose multiple (1924) by Lhermitte et al.\u00a0and Gutre.\u00a0Lhermitte described this phenomenon in patients with multiple sclerosis and other spinal cord diseases. It was then further hypothesized that it resulted from irritation and inflammation of the spinal cord, likely in the posterior and lateral columns. [1]", "contents": "Lhermitte Sign -- Introduction. Lhermitte's sign (also known as Lhermitte's phenomenon\u00a0or the barber chair phenomenon) is the term used that describes a transient sensation of an electric shock that extends down the spine and extremities upon flexion and/or movement of the neck. It was first described by Marie and Chatelin in 1917, but was\u00a0erroneously first credited to Babinski and Dubois,\u00a0and thenafter credited to Jean Jaque Lhermitte through the seminal paper Les douleurs \u00e0 type de d\u00e9charge \u00e9lectrique cons\u00e9cutives \u00e0 la flexion c\u00e9phalique dans la scl\u00e9rose en plaques: Un cas de forme sensitive de la scl\u00e9rose multiple (1924) by Lhermitte et al.\u00a0and Gutre.\u00a0Lhermitte described this phenomenon in patients with multiple sclerosis and other spinal cord diseases. It was then further hypothesized that it resulted from irritation and inflammation of the spinal cord, likely in the posterior and lateral columns. [1]"}
{"id": "article-24241_3", "title": "Lhermitte Sign -- Introduction", "content": "Lhermitte's sign is also classified as one of the paroxysmal pain syndromes of multiple sclerosis, a chronic, predominantly immune-mediated disease of the central nervous system. It is\u00a0among the most common causes of neurological disability in young adults globally. It can cause many other neurological\u00a0clinical symptoms, including mononuclear painful visual loss, spinal cord hemiparesis, mono/paraparesis, hypoesthesia, dysesthesia, paraesthesia, urinary and/or sphincter dysfunction, diplopia, oscillopsia, vertigo, gait ataxia, dysmetria, intentional/postural tremor, facial paresis, faciobrachial\u2013crural hemiparesis, and\u00a0faciobrachial\u2013crural hemihypesthesia. [2] Lhermitte's sign should not be confused with the Uhthoff phenomenon, another finding in\u00a0multiple sclerosis patients that is defined\u00a0by heat sensitivity after prolonged heat exposure, saunas, and hot tubs. [3] [4] [5]", "contents": "Lhermitte Sign -- Introduction. Lhermitte's sign is also classified as one of the paroxysmal pain syndromes of multiple sclerosis, a chronic, predominantly immune-mediated disease of the central nervous system. It is\u00a0among the most common causes of neurological disability in young adults globally. It can cause many other neurological\u00a0clinical symptoms, including mononuclear painful visual loss, spinal cord hemiparesis, mono/paraparesis, hypoesthesia, dysesthesia, paraesthesia, urinary and/or sphincter dysfunction, diplopia, oscillopsia, vertigo, gait ataxia, dysmetria, intentional/postural tremor, facial paresis, faciobrachial\u2013crural hemiparesis, and\u00a0faciobrachial\u2013crural hemihypesthesia. [2] Lhermitte's sign should not be confused with the Uhthoff phenomenon, another finding in\u00a0multiple sclerosis patients that is defined\u00a0by heat sensitivity after prolonged heat exposure, saunas, and hot tubs. [3] [4] [5]"}
{"id": "article-24241_4", "title": "Lhermitte Sign -- Etiology", "content": "Lhermitte's sign (LS) is not a disease but more of a sign or symptom. The\u00a0sign is suggestive of a lesion or compression of the\u00a0lower brainstem or the upper cervical spinal cord. It is a paroxysmal sensation or neuropathic pain that can develop as a result of direct or indirect\u00a0demyelinating lesions in the brain and/or spinal cord and is triggered by the flexion or movement of the neck. More specifically, the neck motion activates ascending spinothalamic tracts at the cervical level that has been sensitized by the underlying process that caused the cervical spine lesion. [5] This view is\u00a0supported by an MRI study of plaque formations in the cervical spine, which was found in 95% of those reporting a history of LS compared with 52% of those who did not report the sign. [6]", "contents": "Lhermitte Sign -- Etiology. Lhermitte's sign (LS) is not a disease but more of a sign or symptom. The\u00a0sign is suggestive of a lesion or compression of the\u00a0lower brainstem or the upper cervical spinal cord. It is a paroxysmal sensation or neuropathic pain that can develop as a result of direct or indirect\u00a0demyelinating lesions in the brain and/or spinal cord and is triggered by the flexion or movement of the neck. More specifically, the neck motion activates ascending spinothalamic tracts at the cervical level that has been sensitized by the underlying process that caused the cervical spine lesion. [5] This view is\u00a0supported by an MRI study of plaque formations in the cervical spine, which was found in 95% of those reporting a history of LS compared with 52% of those who did not report the sign. [6]"}
{"id": "article-24241_5", "title": "Lhermitte Sign -- Etiology", "content": "Other etiologies that have been shown to cause this sign, in addition to multiple sclerosis, include conditions like Bechet's disease, transverse myelitis, systemic lupus erythematosus (SLE), herpes zoster, Arnold-Chiari malformation, tumor progression causing spinal cord compression, radiculopathy, cervical spondylitis, transverse myelitis, syringomyelia, vitamin b12 deficiency, nitric oxide toxicity, subacute combined degeneration of the cord, radiation myelopathy, and chemoradiation. It is preferentially present in patients with cervical demyelinating lesions and abnormal nerve conduction studies. It is not a sensitive or specific sign for any of the disorders mentioned.\u00a0Neck flexion\u00a0irritates demyelinated tracts in the posterior column, causing the electric sensation experienced by patients. [7] [8] [9]", "contents": "Lhermitte Sign -- Etiology. Other etiologies that have been shown to cause this sign, in addition to multiple sclerosis, include conditions like Bechet's disease, transverse myelitis, systemic lupus erythematosus (SLE), herpes zoster, Arnold-Chiari malformation, tumor progression causing spinal cord compression, radiculopathy, cervical spondylitis, transverse myelitis, syringomyelia, vitamin b12 deficiency, nitric oxide toxicity, subacute combined degeneration of the cord, radiation myelopathy, and chemoradiation. It is preferentially present in patients with cervical demyelinating lesions and abnormal nerve conduction studies. It is not a sensitive or specific sign for any of the disorders mentioned.\u00a0Neck flexion\u00a0irritates demyelinated tracts in the posterior column, causing the electric sensation experienced by patients. [7] [8] [9]"}
{"id": "article-24241_6", "title": "Lhermitte Sign -- Epidemiology", "content": "Epidemiological studies of the incidence and prevalence of Lhermitte's sign are scant and give varying data, and there are no available statistics regarding the incidence or prevalence of Lhermitte's sign in today's global population. [10] [11] However, the overall prevalence of Lhermitte's sign in patients with MS ranges from 9 to 41%. [12] [6] One prospective study from 2015 of almost 700 patients with MS showed\u00a0an incidence of about 16%, while another\u00a0older study from 1982\u00a0reported that Lhermitte's sign was experienced by 33.3% of patients, with around\u00a016% reporting having it occurring during their first episode of MS. [13] [14] [5]", "contents": "Lhermitte Sign -- Epidemiology. Epidemiological studies of the incidence and prevalence of Lhermitte's sign are scant and give varying data, and there are no available statistics regarding the incidence or prevalence of Lhermitte's sign in today's global population. [10] [11] However, the overall prevalence of Lhermitte's sign in patients with MS ranges from 9 to 41%. [12] [6] One prospective study from 2015 of almost 700 patients with MS showed\u00a0an incidence of about 16%, while another\u00a0older study from 1982\u00a0reported that Lhermitte's sign was experienced by 33.3% of patients, with around\u00a016% reporting having it occurring during their first episode of MS. [13] [14] [5]"}
{"id": "article-24241_7", "title": "Lhermitte Sign -- Epidemiology", "content": "Despite the low sensitivity in those with MS,\u00a0it has been said to have a very high specificity of 97% for compressive myelopathy as the underlying etiology. [15] One study also compared the prevalence in patients with MS and neuromyelitis optica (NMO). They found that the prevalence of Lhermitte's sign among MS patients (4.3%) was significantly lower than in NMO patients (20.5%) (P < 0.0001). [16] Lhermitte's sign was also found to be more common in patients with a family history of Lhermitte's sign in patients with NMO than in MS, at 12.5% vs. 5.9%, respectively. Although this symptom is typically self-limiting with spontaneous resolution after some weeks, occasionally, patients complain of increasing frequency and pain intensity. [17] The incidence and prevalence of Lhermitte's sign in rarer\u00a0etiologies like vitamin B12 deficiency, Behcet disease, and SSRI discontinuation syndrome,\u00a0among\u00a0others, have not been well studied.", "contents": "Lhermitte Sign -- Epidemiology. Despite the low sensitivity in those with MS,\u00a0it has been said to have a very high specificity of 97% for compressive myelopathy as the underlying etiology. [15] One study also compared the prevalence in patients with MS and neuromyelitis optica (NMO). They found that the prevalence of Lhermitte's sign among MS patients (4.3%) was significantly lower than in NMO patients (20.5%) (P < 0.0001). [16] Lhermitte's sign was also found to be more common in patients with a family history of Lhermitte's sign in patients with NMO than in MS, at 12.5% vs. 5.9%, respectively. Although this symptom is typically self-limiting with spontaneous resolution after some weeks, occasionally, patients complain of increasing frequency and pain intensity. [17] The incidence and prevalence of Lhermitte's sign in rarer\u00a0etiologies like vitamin B12 deficiency, Behcet disease, and SSRI discontinuation syndrome,\u00a0among\u00a0others, have not been well studied."}
{"id": "article-24241_8", "title": "Lhermitte Sign -- Pathophysiology", "content": "The pathophysiology of Lhermitte's sign that\u00a0is associated with the radiographical demyelinating lesions and electrodiagnostic abnormalities on nerve conduction is\u00a0thought to be related to the demyelination of the dorsal columns of the cervical spine.\u00a0Other reasons include compressive myelopathy with reported lesions in the dorsal columns of the caudal medulla. It is also thought to transiently activate neuropathic pain pathways, with a more recent theory being that it implicates glutamatergic signaling and microglial cell activation in the CNS.", "contents": "Lhermitte Sign -- Pathophysiology. The pathophysiology of Lhermitte's sign that\u00a0is associated with the radiographical demyelinating lesions and electrodiagnostic abnormalities on nerve conduction is\u00a0thought to be related to the demyelination of the dorsal columns of the cervical spine.\u00a0Other reasons include compressive myelopathy with reported lesions in the dorsal columns of the caudal medulla. It is also thought to transiently activate neuropathic pain pathways, with a more recent theory being that it implicates glutamatergic signaling and microglial cell activation in the CNS."}
{"id": "article-24241_9", "title": "Lhermitte Sign -- Pathophysiology", "content": "Lhermitte's sign is thought to result from\u00a0ectopic firing and hyperexcitability of demyelinated sensory neurons (in cervical regions of the spinal cord), also\u00a0affecting ascending spinothalamic nociceptive signal transduction and impaired function of inhibitory GABAergic interneurons. Other proposed molecular mechanisms include downstream activated microglia that enhance\u00a0pro-inflammatory cytokine signaling, activation of proteins like bradykinin with B1 and B2 receptors, upregulation of Wnt signaling, CREB phosphorylation, and other transcription factors in the CNS that augment hyperexcitability and pain. [9] [18]", "contents": "Lhermitte Sign -- Pathophysiology. Lhermitte's sign is thought to result from\u00a0ectopic firing and hyperexcitability of demyelinated sensory neurons (in cervical regions of the spinal cord), also\u00a0affecting ascending spinothalamic nociceptive signal transduction and impaired function of inhibitory GABAergic interneurons. Other proposed molecular mechanisms include downstream activated microglia that enhance\u00a0pro-inflammatory cytokine signaling, activation of proteins like bradykinin with B1 and B2 receptors, upregulation of Wnt signaling, CREB phosphorylation, and other transcription factors in the CNS that augment hyperexcitability and pain. [9] [18]"}
{"id": "article-24241_10", "title": "Lhermitte Sign -- History and Physical", "content": "Neck movements, fatigue, stress, heat, and even yawning have been shown to\u00a0trigger Lhermitte's sign. [5] Patients often describe Lhermitte's sign as an electric shock of pain that runs from the\u00a0head down to the back and through the arms and legs. It happens\u00a0when they bend their head down (flex their neck) and touch their chin to their chest. [7] In addition to neck flexion, it has also been described with neck extension (reverse Lhermitte's sign). [19]", "contents": "Lhermitte Sign -- History and Physical. Neck movements, fatigue, stress, heat, and even yawning have been shown to\u00a0trigger Lhermitte's sign. [5] Patients often describe Lhermitte's sign as an electric shock of pain that runs from the\u00a0head down to the back and through the arms and legs. It happens\u00a0when they bend their head down (flex their neck) and touch their chin to their chest. [7] In addition to neck flexion, it has also been described with neck extension (reverse Lhermitte's sign). [19]"}
{"id": "article-24241_11", "title": "Lhermitte Sign -- Evaluation", "content": "There is no routine laboratory, radiological, or ancillary test to assess or manage Lhermitte's sign. Some prospective studies link the sign with radiographic and electrodiagnostic findings. One study showed a correlation between the clinical signs, the presence of a demyelinating lesion on cervical MRI, and the conduction delay of median and tibial somatosensory evoked potentials (SSEP). The results were clinically and statistically significant. However, the consensus is that the history and physical exam findings are sufficient. [13] [7]", "contents": "Lhermitte Sign -- Evaluation. There is no routine laboratory, radiological, or ancillary test to assess or manage Lhermitte's sign. Some prospective studies link the sign with radiographic and electrodiagnostic findings. One study showed a correlation between the clinical signs, the presence of a demyelinating lesion on cervical MRI, and the conduction delay of median and tibial somatosensory evoked potentials (SSEP). The results were clinically and statistically significant. However, the consensus is that the history and physical exam findings are sufficient. [13] [7]"}
{"id": "article-24241_12", "title": "Lhermitte Sign -- Treatment / Management", "content": "There is an absence of level I evidence-based treatment for those suffering from Lhermitte's sign, given the vast number of etiologies causing the condition. LS rarely elicits severe pain and discomfort as it is usually a benign finding and self-resolves. Treatment of the underlying condition, like in MS, and surgically addressing any of the compressive anatomical causes are recommended. Few reports and anecdotal evidence show that carbamazepine,\u00a0oxcarbazepine, and gabapentin may benefit some patients. [20] [21] Inhibition of pro-inflammatory cytokine signaling, augmentation of inhibitory cytokine signaling, and blockade of chemokine receptor-mediated inflammatory cell recruitment to the CNS has the potential for future therapies for more severe manifestations of MS-associated neuropathic pain. [9]", "contents": "Lhermitte Sign -- Treatment / Management. There is an absence of level I evidence-based treatment for those suffering from Lhermitte's sign, given the vast number of etiologies causing the condition. LS rarely elicits severe pain and discomfort as it is usually a benign finding and self-resolves. Treatment of the underlying condition, like in MS, and surgically addressing any of the compressive anatomical causes are recommended. Few reports and anecdotal evidence show that carbamazepine,\u00a0oxcarbazepine, and gabapentin may benefit some patients. [20] [21] Inhibition of pro-inflammatory cytokine signaling, augmentation of inhibitory cytokine signaling, and blockade of chemokine receptor-mediated inflammatory cell recruitment to the CNS has the potential for future therapies for more severe manifestations of MS-associated neuropathic pain. [9]"}
{"id": "article-24241_13", "title": "Lhermitte Sign -- Treatment / Management", "content": "Interestingly, a case series demonstrated that the use of extracranial picotesla range pulsed electromagnetic fields (EMFs) effectively treated patients with Lhermitte's sign. One theory is that the reduction of axonal excitability\u00a0occurs through the modulation of\u00a0ionic membrane permeability. The second theory involves modulating pain control systems through neurotransmitter activity and pineal melatonin functions, as discussed earlier. [22] [23]", "contents": "Lhermitte Sign -- Treatment / Management. Interestingly, a case series demonstrated that the use of extracranial picotesla range pulsed electromagnetic fields (EMFs) effectively treated patients with Lhermitte's sign. One theory is that the reduction of axonal excitability\u00a0occurs through the modulation of\u00a0ionic membrane permeability. The second theory involves modulating pain control systems through neurotransmitter activity and pineal melatonin functions, as discussed earlier. [22] [23]"}
{"id": "article-24241_14", "title": "Lhermitte Sign -- Differential Diagnosis", "content": "The differential diagnosis of Lhermitte sign, besides MS, has been reported in the literature and includes tumor progression causing spinal cord compression, radiculopathy, cervical spondylitis, transverse myelitis, subacute combined degeneration of the cord, radiation myelopathy, parasitic invasion of the cord, Arnold-Chiari malformation, high dose chemoradiation (cisplatin), trauma, arachnoiditis, Herpes zoster toxicity, syringomyelia,\u00a0 Behcet disease, vitamin B12 deficiency, nitric oxide toxicity, systemic lupus erythematous, and post-dural puncture headache. [24] [25] [26] [19]", "contents": "Lhermitte Sign -- Differential Diagnosis. The differential diagnosis of Lhermitte sign, besides MS, has been reported in the literature and includes tumor progression causing spinal cord compression, radiculopathy, cervical spondylitis, transverse myelitis, subacute combined degeneration of the cord, radiation myelopathy, parasitic invasion of the cord, Arnold-Chiari malformation, high dose chemoradiation (cisplatin), trauma, arachnoiditis, Herpes zoster toxicity, syringomyelia,\u00a0 Behcet disease, vitamin B12 deficiency, nitric oxide toxicity, systemic lupus erythematous, and post-dural puncture headache. [24] [25] [26] [19]"}
{"id": "article-24241_15", "title": "Lhermitte Sign -- Radiation Oncology", "content": "Lhermitte's sign has been noted as a potential side effect of radiation oncology therapies, specifically as an early delayed radiation injury. These often occur within four months of radiation therapy. [27] [25]", "contents": "Lhermitte Sign -- Radiation Oncology. Lhermitte's sign has been noted as a potential side effect of radiation oncology therapies, specifically as an early delayed radiation injury. These often occur within four months of radiation therapy. [27] [25]"}
{"id": "article-24241_16", "title": "Lhermitte Sign -- Medical Oncology", "content": "Cisplatin or docetaxel neurotoxicity has been tied to Lhermitte's sign. [25]", "contents": "Lhermitte Sign -- Medical Oncology. Cisplatin or docetaxel neurotoxicity has been tied to Lhermitte's sign. [25]"}
{"id": "article-24241_17", "title": "Lhermitte Sign -- Prognosis", "content": "Lhermitte's sign or syndrome is not a disease process, and it is usually intermittent upon neck flexion. The prognosis of the disease process underlying the Lhermitte's sign is variable.", "contents": "Lhermitte Sign -- Prognosis. Lhermitte's sign or syndrome is not a disease process, and it is usually intermittent upon neck flexion. The prognosis of the disease process underlying the Lhermitte's sign is variable."}
{"id": "article-24241_18", "title": "Lhermitte Sign -- Complications", "content": "There are no known complications related to Lhermitte's sign. However, it is occasionally reported as a facet of\u00a0a discontinuation syndrome related to\u00a0certain medications. Psychotropic medications such as\u00a0SSRIs\u00a0and SNRIs, specifically paroxetine and venlafaxine, have been shown to have a reported association. Fluoxetine, given\u00a0the extended length of its\u00a0half-life, has less likelihood of causing Lhermitte's sign upon sudden discontinuation. [24] On the other hand, paroxetine has a shorter half-life and is more likely to cause discontinuation syndrome. In dentistry, there have been studies that found Lhermitte's sign associated with nitrous oxide abuse (caused by depletion of vitamin B12). [26] [19]", "contents": "Lhermitte Sign -- Complications. There are no known complications related to Lhermitte's sign. However, it is occasionally reported as a facet of\u00a0a discontinuation syndrome related to\u00a0certain medications. Psychotropic medications such as\u00a0SSRIs\u00a0and SNRIs, specifically paroxetine and venlafaxine, have been shown to have a reported association. Fluoxetine, given\u00a0the extended length of its\u00a0half-life, has less likelihood of causing Lhermitte's sign upon sudden discontinuation. [24] On the other hand, paroxetine has a shorter half-life and is more likely to cause discontinuation syndrome. In dentistry, there have been studies that found Lhermitte's sign associated with nitrous oxide abuse (caused by depletion of vitamin B12). [26] [19]"}
{"id": "article-24241_19", "title": "Lhermitte Sign -- Consultations", "content": "In the case of multiple sclerosis, an experienced neurologist should be consulted if demyelinating disorders are suspected.", "contents": "Lhermitte Sign -- Consultations. In the case of multiple sclerosis, an experienced neurologist should be consulted if demyelinating disorders are suspected."}
{"id": "article-24241_20", "title": "Lhermitte Sign -- Deterrence and Patient Education", "content": "No active intervention is required by healthcare providers beyond education and reassurance; the syndrome usually resolves spontaneously over a period of months to a year. In rare cases, it can be treated with neuropathic pain medication if refractory and recurrent. [28]", "contents": "Lhermitte Sign -- Deterrence and Patient Education. No active intervention is required by healthcare providers beyond education and reassurance; the syndrome usually resolves spontaneously over a period of months to a year. In rare cases, it can be treated with neuropathic pain medication if refractory and recurrent. [28]"}
{"id": "article-24241_21", "title": "Lhermitte Sign -- Pearls and Other Issues", "content": "Lhermitte's sign generally occurs with pathologies involving the cervical spinal cord but is not specific to etiology.", "contents": "Lhermitte Sign -- Pearls and Other Issues. Lhermitte's sign generally occurs with pathologies involving the cervical spinal cord but is not specific to etiology."}
{"id": "article-24241_22", "title": "Lhermitte Sign -- Pearls and Other Issues", "content": "It often occurs in patients with\u00a0multiple sclerosis, cervical spondylotic myelopathy, chemotherapy, radiation myelopathy, and B12 deficiency, among others.", "contents": "Lhermitte Sign -- Pearls and Other Issues. It often occurs in patients with\u00a0multiple sclerosis, cervical spondylotic myelopathy, chemotherapy, radiation myelopathy, and B12 deficiency, among others."}
{"id": "article-24241_23", "title": "Lhermitte Sign -- Pearls and Other Issues", "content": "Increased spinal cord metabolic activity and positive positron emission tomography (PET) imaging have been described in association with Lhermitte's sign.", "contents": "Lhermitte Sign -- Pearls and Other Issues. Increased spinal cord metabolic activity and positive positron emission tomography (PET) imaging have been described in association with Lhermitte's sign."}
{"id": "article-24241_24", "title": "Lhermitte Sign -- Pearls and Other Issues", "content": "The overall incidence and prevalence of Lhermitte symptoms are difficult to estimate but more studied in MS patients.", "contents": "Lhermitte Sign -- Pearls and Other Issues. The overall incidence and prevalence of Lhermitte symptoms are difficult to estimate but more studied in MS patients."}
{"id": "article-24241_25", "title": "Lhermitte Sign -- Pearls and Other Issues", "content": "Patients can experience Lhermitte's sign intermittently\u00a0as it does not have to always happen with the same degree of neck flexion. It may be infrequent or occur with slight to dramatic flexion of the head or neck as well as with extension of the neck.", "contents": "Lhermitte Sign -- Pearls and Other Issues. Patients can experience Lhermitte's sign intermittently\u00a0as it does not have to always happen with the same degree of neck flexion. It may be infrequent or occur with slight to dramatic flexion of the head or neck as well as with extension of the neck."}
{"id": "article-24241_26", "title": "Lhermitte Sign -- Pearls and Other Issues", "content": "Delayed onset Lhermitte's sign has been reported following head and/or neck trauma. This occurs\u00a0several months following injury, without associated neurological symptoms or pain, and typically resolves within 12 months.", "contents": "Lhermitte Sign -- Pearls and Other Issues. Delayed onset Lhermitte's sign has been reported following head and/or neck trauma. This occurs\u00a0several months following injury, without associated neurological symptoms or pain, and typically resolves within 12 months."}
{"id": "article-24241_27", "title": "Lhermitte Sign -- Pearls and Other Issues", "content": "As a misnomer, Lhermitte's \"sign\" is not truly a sign, at least in the traditional medical terminology. Rather, it is a symptom. [29] [30] [28]", "contents": "Lhermitte Sign -- Pearls and Other Issues. As a misnomer, Lhermitte's \"sign\" is not truly a sign, at least in the traditional medical terminology. Rather, it is a symptom. [29] [30] [28]"}
{"id": "article-24241_28", "title": "Lhermitte Sign -- Enhancing Healthcare Team Outcomes", "content": "Lhermitte's sign is a symptom often secondary to an underlying chronic disease like (but not limited to) MS, which can sometimes follow an unpredictable\u00a0trajectory. It is best to enhance patient outcomes by integrating an interprofessional team-based approach, including nurses, mid-level practitioners, physical therapists, and physicians\u00a0should be used\u00a0in managing patients with with multiple sclerosis or other conditions that can produce this sign. All practitioners with diagnostic and assessment duties should be familiar with how to perform the sign and its clinical significance. They should also be able to explain the test and its significance in laypeople's terms to the patient. Consider speaking to the patient about implementing new clinicians and services to their overall care, such as palliative medicine, as such resources can offer a new range of support to the family and the patient. [Level 5]", "contents": "Lhermitte Sign -- Enhancing Healthcare Team Outcomes. Lhermitte's sign is a symptom often secondary to an underlying chronic disease like (but not limited to) MS, which can sometimes follow an unpredictable\u00a0trajectory. It is best to enhance patient outcomes by integrating an interprofessional team-based approach, including nurses, mid-level practitioners, physical therapists, and physicians\u00a0should be used\u00a0in managing patients with with multiple sclerosis or other conditions that can produce this sign. All practitioners with diagnostic and assessment duties should be familiar with how to perform the sign and its clinical significance. They should also be able to explain the test and its significance in laypeople's terms to the patient. Consider speaking to the patient about implementing new clinicians and services to their overall care, such as palliative medicine, as such resources can offer a new range of support to the family and the patient. [Level 5]"}
{"id": "article-24241_29", "title": "Lhermitte Sign -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Lhermitte Sign -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}